---
phase: 6
title: "Production Root Product Kill Gate"
status: completed
outcome: no-go
priority: P1
effort: "not estimated"
dependencies: [1]
tier: thinking
---

# Phase 6: Production Root Product Kill Gate

> **Required — deviation-log:** Record every decision, deviation, or surprise when it occurs. Escalate irreversible procurement, OTP, lifecycle, or public-contract changes.

## Context Links
- `docs/decisions/0006-block-production-root-pending-exact-product-evidence.md`
- `research/phase-06-production-root-kill-gate.md`
- `research/protected-root-report.json`
- `reports/security-judge.json` findings KMS-ARCH-002, 003, 005, 008, 010

## Overview
Complete the no-code product kill gate through its specified NO-GO branch. No production root product is selected, and no procurement, OTP, firmware, board, provisioning, manufacturing, or other irreversible action is approved.

## Key Insights
Public evidence can establish useful design capability or production deployment without identifying one exact, procurable, supported Cellos product. The reviewed evidence does not jointly satisfy the content-enforcing command, immutable AP boot, protected state, authenticated time, lifecycle, board, provisioning, and support gates. Completion records that evidence-backed refusal; it does not reduce the production requirements.

## Requirements
- Evaluate exact product identity, procurement/support, pinned production software, and applicable errata without inferring an SKU or configuration from a family or design release.
- Require a versioned protocol that reconstructs and validates complete PKCS#10 `CertificationRequestInfo` and TLS 1.3 `CertificateVerify` content inside the protected boundary and makes every generic-sign bypass absent or cryptographically unreachable.
- Require immutable, non-circular AP/board boot authorization plus rollback-resistant, power-loss-atomic protected state and authenticated time.
- Require evidence-backed lifecycle, entropy, OTP, provisioning, debug/rescue, update, RMA, zeroization, revocation, manufacturing, board, and support contracts.
- If any conjunctive gate lacks evidence, select no product, approve no irreversible action, and block Phases 7–8 without fallback or disabled placeholder completion.
- Preserve Phases 1–3 and the product-independent Phase 4 software contract; Phase 5 remains `DEV_REFERENCE` only.

## Architecture
The production decision boundary is `one coherent vendor-signed package → architecture/security/procurement/board review → superseding GO ADR naming one exact product`. The current path stops before the package: `reviewed public evidence → NO-GO → fail-closed production block`.

## Assumptions
- No product capability, availability, firmware baseline, board fit, provisioning service, or support term is assumed from generic, masked, reference, or development evidence.
- A future vendor-private package may enable a fresh review, but its existence and outcome are not assumed.

## Related Code Files
| File | Action | Test impact |
|---|---|---|
| implementation files | None | no code was approved or changed by this gate |
| `docs/decisions/0006-block-production-root-pending-exact-product-evidence.md` | Cross-link | accepted decision and reopening criteria |
| `research/phase-06-production-root-kill-gate.md` | Cross-link | evidence and active refutation |
| Phase 7 and Phase 8 plans | Modify | replace speculative execution with blocked acceptance gates |

## Implementation Steps
1. Evaluated the candidates against every conjunctive product, protocol, boot, state, time, lifecycle, board, provisioning, procurement, and support gate.
2. Actively refuted the NO-GO and found no evidence-complete candidate without weakening a mandatory gate.
3. Selected no product and approved no purchase, sample order, firmware, board, OTP/lifecycle transition, provisioning, manufacturing, or RMA action.
4. Accepted ADR-0006 and retained the ADR-0005 fail-closed production prerequisite.
5. Blocked Phases 7–8 behind one vendor-signed evidence package, fresh reviews, and a superseding GO ADR naming the exact product.

## Todo List
- [x] Complete the evidence matrix and active refutation.
- [x] Take the specified NO-GO branch because at least one mandatory gate remained unsupported for every candidate.
- [x] Record no product selection and no irreversible approval.
- [x] Preserve Phase 4 as product-independent software integration and Phase 5 as `DEV_REFERENCE` only.
- [x] Replace Phase 7–8 speculative procedures with reopening and acceptance gates.

External reopening research (not Phase 6 completion) remains visibly unmet:
- [ ] Receive one coherent vendor-signed package satisfying every ADR-0006 evidence category for one exact deployment.
- [ ] Pass fresh architecture, security, procurement, and board reviews, then accept a superseding GO ADR naming that product.

## Test Scenario Matrix
| Priority | Scenario | Recorded outcome |
|---|---|---|
| Critical | exact product or pinned production TCB cannot be evidenced | NO-GO; no product inferred |
| Critical | generic sign/digest or caller-supplied signed body remains reachable | candidate rejected |
| Critical | immutable AP boot, protected state, or authenticated time is unsupported | candidate rejected |
| Critical | board, lifecycle, provisioning, procurement, or support evidence is incomplete | candidate rejected |
| Critical | FPGA, QEMU, development, or disabled plumbing proposed as completion | production credit denied |
| Critical | mandatory gate remains unmet after refutation | Phases 7–8 stay blocked |

## Success Criteria
- [x] Every original production gate was evaluated without scope reduction.
- [x] The GO branch was rejected rather than filled with a vague product choice.
- [x] The specified NO-GO branch closed the phase with no selected product or irreversible approval.
- [x] Production remains fail closed and `BLOCKED_BY_ADR_0006`.
- [x] Phases 1–3 remain valid; Phase 4 retains only its software entry gates; Phase 5 remains non-production evidence.

## Completion and Review Evidence
- Phase 6 closed **NO-GO**; accepted ADR-0006 and `research/phase-06-production-root-kill-gate.md` record the decision, evidence matrix, and active refutation.
- Final security and consistency re-reviews returned GO with zero residual findings; `research/protected-root-report.json` parsed, and the master `plan.md` size check passed at 77 lines.
- This decision-only closure approves no product or irreversible action; the external reopening items above remain unmet and Phases 7–8 remain blocked.

## Risk Assessment
The principal risk is treating gate completion as product approval. `completed / NO-GO` means the selection process reached its defined blocking outcome; it does not approve silicon, firmware, procurement, OTP, board, manufacturing, provisioning, or production readiness.

## Security Considerations
No AP assertion, generic signing primitive, masked family, reference design, simulation, development board, or disabled adapter may satisfy the protected product boundary. Production remains unavailable without exact evidence and independent review.

## Next Steps
Reopen only after one vendor-signed package binds all eight ADR-0006 evidence categories to the same proposed deployment. Receipt permits fresh architecture, security, procurement, and board review; implementation remains prohibited until all items pass without inference and a superseding GO ADR names the exact product.

## Deviation Log
2026-08-26 — Closed through the planned NO-GO branch after the evidence review and active refutation found no reviewed candidate that jointly satisfied every mandatory gate. ADR-0006 records no product selection or irreversible approval, preserves Phase 4 as product-independent software work, and blocks Phases 7–8 pending its full reopening process.
